Prime Medicine, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Prime Medicine, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Prime Medicine, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$134K, a 532% decline year-over-year.
  • Prime Medicine, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$108K, a 25.5% increase year-over-year.
  • Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2023 was -$279K, a 70.6% increase from 2022.
  • Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2022 was -$948K, a 95.1% decline from 2021.
  • Prime Medicine, Inc. annual Income Tax Expense (Benefit) for 2021 was -$486K, a 126% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$279K +$669K +70.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 -$948K -$462K -95.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 -$486K -$2.35M -126% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $1.87M Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.